Neuroendovascular Non-coils Market 2016-2020

Overview of the neuroendovascular non-coils market

According to the market research analysts at Technavio, the global neuroendovascular non-coils market is anticipated to witness impressive growth and will post a staggering CAGR of close to 13% over the forecast period. With rising demand for intracranial stenting procedures, the neuroendovascular non-coils market is expected to have a positive outlook over the coming years. The number of individuals with cerebral aneurysm around the world is increasing significantly, which has led to a sharp rise in demand for intracranial stenting procedures. For instance, in the US, it is estimated that intracranial cerebral atherosclerosis causes 40,000–60,000 new strokes per year. This has driven the demand for coils and non-coils, which are rampantly adopted by hospitals and neurological centers. Non-coils such as stents are extensively used due to better navigability and easy deployment in tortuous vessels for optimal cerebral circulation. The introduction of new intracranial devices with flow diverters is feasible and efficient with high complete occlusion rates. Moreover, intraoperative neurophysiological monitoring systems serve as a reliable tool for continuous functional monitoring of individuals undergoing large-caliber vessel EC-IC bypass surgery, leading to the augmented adoption of intracranial stenting procedures.

The increasing number of ongoing clinical trials is one of the recent trends spurring this market’s growth prospects during the forecast period. The ongoing trials for non-coil technology in treating intracranial aneurysms have shown potential outcomes in addressing high recanalization rates when compared to other treatment procedures such as coil embolization. However, more clinical evidence is required for surgeons to have a positive indication to use non-coil techniques in treating intracranial aneurysms. The market is expected to get new FDA product launches, which will propel this market’s growth prospects over the next four years.

Competitive landscape and key vendors

The global neuroendovascular non-coils market is highly fragmented owing to the presence of large, medium, and small-sized companies. The advances in technology and new product launches will increase the competition among the existing vendors. To remain competitive in the market, the majority of vendors are adopting different strategies to help them enhance their presence in the market. Although the leading vendors hold the majority of the market shares, factors such as innovation, greater product development, and the choice is bound to change the competitive landscape of the market.

 Key vendors in this market are -

• DeBuy Synthes
• Medtronic
• MicroVention
• Stryker

Other prominent vendors in the market include Abiomed, AdvanSource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, Angioslide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Innovative Cardiovascular Solutions, Keystone Heart, St. Jude Medical, phenox, InspireMD, Acandis, and Transverse Medical. 

Segmentation by product type and analysis of the neuroendovascular non-coils market

• Neurovascular stents
• Access devices
• Flow diverter devices
• Others (liquid embolic agents, embolic protection device, and clot retrievers)

During 2015, the neurovascular stents was the highest revenue generating product segment and will continue to lead the market in the coming years. A neurovascular stent is a small, flexible, tube-like device made of fabric supported by a metal mesh. It is used to treat several cerebral conditions such as stenosis formation in the blood vessels and ischemic stroke, and aneurysm. It is also used to re-establish the blood flow through a stenosis vessel. The growing clinical trials are expected to drive the adoption rates of neurovascular stents. Additionally, technological advancements are also expected to contribute to this segment’s growth until the end of 2020.

Geographical segmentation and analysis of the neuroendovascular non-coils market

• Americas
• APAC
• EMEA

In terms of geography, the Americas dominated the global neuroendovascular non-coils market during 2015 and will continue its dominance over the next four years. The growth of this market in the Americas, especially the US, is the rising prevalence of cerebral disorders such as ischemic stroke, stenosis, brain aneurysm, and malformation. The implementation of new medical standards is also one of the major factors contributing to the growth of the market in the region.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global neuroendovascular non-coils market?
• What are the key market trends impacting the growth of the global neuroendovascular non-coils market?
• What are the challenges to market growth?
• Who are the key vendors in the global neuroendovascular non-coils market?
• What are the market opportunities and threats faced by the vendors in the global neuroendovascular non-coils market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global neuroendovascular non-coils market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global Vascular Stents Market 2016-2020
• Global Non-Vascular Stents Market 2016-2020
• Global Drug-Eluting Stent Market 2016-2020
• Global Vascular Guidewires Market 2016-2020

Neuroendovascular non-coil equipment is primarily used for the treatment of an unruptured or ruptured brain aneurysm, which is a weakened area in the artery wall. The whole treatment procedure is known as endovascular embolization. During this procedure, the neuroendovascular non-coil devices including stents, flow diverters, liquid embolic glues block the flow of blood in an aneurysm. The interventional neuroradiologist performs neuroendovascular non-coiling treatment by using fluoroscopic imaging guidance under general anesthesia administration. Neuroendovascular non-coils are used as an alternative to surgical clipping for the aneurysm medication.  The growing incidences of brain aneurysm and rising demand for minimally-invasive endovascular surgeries have necessitated the use of neuroendovascular non-coil devices. Among all geographies, the Americas has been identified as the most promising region in this market space, in terms of growth rate.

The report, global neuroendovascular non-coils market, is part of Technavio’s healthcare and life sciences research portfolio. This portfolio provides a comprehensive market analysis along with the market share, market sizing, and market segmentations covering areas such as cardiovascular and metabolic disorders, central nervous system, oncology, medical imaging, life science research tools, and vaccines. These market research reports provide a perspective on the various market opportunities and market threats along with the key trends that would influence the market growth during the forecast period. It presents insights into the changing competitive landscape and a detailed profiling and market analysis of the vendors. Also covered in the research are the key regions or countries that would have an impact on the market during the assessment years.